Search details
1.
Functional genomic landscape of cancer-intrinsic evasion of killing by T cells.
Nature
; 586(7827): 120-126, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32968282
2.
MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial.
Radiology
; 310(3): e231473, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38441092
3.
Contrast-Enhanced Ultrasound of the Indeterminate Renal Mass, From the AJR "How We Do It" Special Series.
AJR Am J Roentgenol
; 2024 Feb 28.
Article
in English
| MEDLINE | ID: mdl-38415576
4.
Estimated glomerular filtration rate from the renal hypothermia trial: clinical implications.
BJU Int
; 132(4): 452-460, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37409827
5.
Applying Quality Indicators to Examine Quality of Care During Active Surveillance in Low-Risk Prostate Cancer: A Population-Based Study.
J Natl Compr Canc Netw
; 21(5): 465-472.e9, 2023 05.
Article
in English
| MEDLINE | ID: mdl-37156486
6.
Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions.
Eur Radiol
; 33(8): 5840-5850, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37074425
7.
Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer.
Radiology
; 304(3): 600-608, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35608445
8.
Effect of 18F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.
Radiology
; 303(2): 414-422, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35076300
9.
Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men.
Radiology
; 305(2): 390-398, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35852425
10.
Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratification.
Mod Pathol
; 35(11): 1695-1701, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35676330
11.
A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results from the Canadian Kidney Cancer Information System.
J Urol
; 208(4): 804-812, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35686812
12.
Incident Cancer Detection During Multiple Waves of COVID-19: The Tsunami After the Earthquake.
J Natl Compr Canc Netw
; 20(11): 1190-1192, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36351330
13.
Incident Cancer Detection During the COVID-19 Pandemic.
J Natl Compr Canc Netw
; 20(3): 276-284, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-35104788
14.
Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy.
Eur Radiol
; 32(11): 7544-7554, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-35507051
15.
Cost-Effectiveness Analysis of Negative Pressure Wound Therapy to Prevent Surgical Site Infection After Elective Colorectal Surgery.
Dis Colon Rectum
; 65(5): 767-776, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-34840300
16.
Exploring the value of using patient-oriented MRI reports in clinical practice - a pilot study.
Support Care Cancer
; 30(8): 6857-6876, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35534628
17.
Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysis.
Prostate
; 81(5): 286-294, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33599318
18.
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.
Radiology
; 300(2): 369-379, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34032510
19.
MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
Radiology
; 298(3): 695-703, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33529137
20.
Impact of Time to Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell Carcinoma.
J Urol
; 205(1): 78-85, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32614274